An interventional study of physical activity and usual care in Subclinical hypothyroïdism, Non-Alcoholic Fatty Liver Disease and Primary Open Angle Glaucoma, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to female participants aged 65 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-05-20.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated
hypthyroidism elder females (n=40) with glaucoma and fatty liver issues will randomly divided into group number 1 (n=20) that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month or group number II (n=20) that will receive levothyroxine only
1,617 studies on the registry are indexed under Non-alcoholic Fatty Liver Disease; 324 are open to participants now.
This study's planned enrollment of 40 is below the median of 60 across 1,176 interventional studies indexed under Non-alcoholic Fatty Liver Disease.
Browse Non-alcoholic Fatty Liver Disease studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
hypthyroidism elder females (n=20) with glaucoma and fatty liver issues recive their levothyroxine and physical activity program on treadmill thrice weekly for 6 month
Behavioral: physical activity
hypthyroidism elder females (n=20) with glaucoma and fatty liver issues will recive their levothyroxine only
Other: usual care
hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month
hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine only
intraocular pressure
it will be assessed in both eyes
Time frame: 6 months
body mass index
it will be assessed on empty stomach and bladder
Time frame: 6 months
waist circumfrence
it will be assessed by tape at umblical level
Time frame: 6 months
systolic blood pressure
it will be assessed by sphygmomanmometer
Time frame: 6 months
diastolic blood pressure
it will be assessed by sphygmomanmometer
Time frame: 6 months
glaucoma assocaited life quality survey
it is a questionaire evaluates life quality
Time frame: 6 months
triglyceridss
it will be assessed in serum
Time frame: 6 months
high density lipoproteines
it will be assesed in serum
Time frame: 6 months
alanine transamianses
it will be assessed in serum
Time frame: 6 months
aspartate trasnamiansses
it will be assessed in serum
Time frame: 6 months
physical conclusion of short form survey
it will assess physical quality of lifes of females
Time frame: 6 months
Mental conclusion of short form survey
it will assess physical quality of lifes of females
Time frame: 6 months
thyroid stimualting horomone
it will be assessed in serum
Time frame: 6 months
fasting glycemia value
it will be assessed in serum
Time frame: 6 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Non-alcoholic Fatty Liver Disease →